Phibro Animal Health (PAHC) Assets Average (2014 - 2026)
Phibro Animal Health's (PAHC) quarterly Assets Average came in at $1.4 billion in Q1 2026, up 9.52% year-on-year from $1.3 billion in Q1 2025, and up 2.14% quarter-over-quarter from $1.4 billion in Q4 2025.
Phibro Animal Health (PAHC) Assets Average (2014 - 2026) Analysis & Trends
Phibro Animal Health's Assets Average history runs 13 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- On a quarterly basis, Assets Average rose 9.52% year-over-year to $1.4 billion in Q1 2026; TTM through Mar 2026 was $1.4 billion, a 9.52% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 19.94% from the prior year.
- Assets Average advanced to $1.4 billion in Q1 2026 per PAHC's latest filing, from $1.4 billion in the prior quarter.
- Across five years, Assets Average topped out at $1.4 billion in Q1 2026 and bottomed at $882.6 million in Q1 2022.
- The 5-year median for Assets Average is $974.2 million (2024), against an average of $1.1 billion.
- Across the five-year window, Assets Average grew 0.65% in 2024 and soared 40.95% in 2025, its largest moves.
- Year by year, Assets Average stood at $955.1 million in 2022, then gained by 1.41% to $968.6 million in 2023, then rose by 16.24% to $1.1 billion in 2024, then grew by 23.95% to $1.4 billion in 2025, then gained by 2.14% to $1.4 billion in 2026.
- Per Business Quant, the three latest PAHC Assets Average figures stand at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.4 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 1.43 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 Bn |
| Dec 31, 2025 | 1.40 Bn |
| Sep 30, 2025 | 1.37 Bn |
| Jun 30, 2025 | 1.34 Bn |
| Mar 31, 2025 | 1.30 Bn |
| Dec 31, 2024 | 1.13 Bn |
| Sep 30, 2024 | 974.24 Mn |
| Jun 30, 2024 | 980.61 Mn |
| Mar 31, 2024 | 975.87 Mn |
| Dec 31, 2023 | 968.62 Mn |
| Sep 30, 2023 | 967.96 Mn |
| Jun 30, 2023 | 968.41 Mn |
| Mar 31, 2023 | 963.63 Mn |
| Dec 31, 2022 | 955.11 Mn |
| Sep 30, 2022 | 940.04 Mn |
| Jun 30, 2022 | 923.94 Mn |
| Mar 31, 2022 | 882.57 Mn |
| Dec 31, 2021 | 842.50 Mn |
| Sep 30, 2021 | 838.68 Mn |
| Jun 30, 2021 | 823.17 Mn |